You are here

November 4, 2019

AdvaMed Commends New Device Incentives in CMS Final Rules

WASHINGTON, D.C. – Scott Whitaker, President and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement today on CMS’s release of final CY 2020 Medicare payment rules – including the CY 2020 Medicare Outpatient Prospective Payment System (OPPS) and Ambulatory Surgery Center final rule and the CY 2020 End Stage Renal Disease (ESRD) Prospective Payment System (PPS) final rule – that support patient access to medical technology innovation:

“The final OPPS and ESRD rule are good news for Medicare beneficiaries as they will help ensure America’s seniors have more timely access to breakthrough and new medtech innovations. The final rules make it easier for new breakthrough technologies to qualify for outpatient transitional passthrough payments in the outpatient hospital setting and for dialysis facilities to receive new add-on payments when using new innovative equipment and supplies that offer substantial improvements in care.

“These changes follow a similar provision in the FY 2020 inpatient hospital rule that AdvaMed has long supported. These rules highlight the continued commitment of HHS Secretary Azar, CMS Administrator Verma, and the Administration to spur access to innovative new technologies for the benefit of American patients.

“We look forward to working closely with CMS on implementation of these final rules, and additional ways to facilitate greater efficiencies in the coverage and payment process.”